Project Number 3R01AG052510-03S2 Agency/Funding Organization NIA Funding Year 2019 View Full Project Details for Escitalopram for Agitation in Alzheimer Disease - Actigraph Supplement Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 10. Clinical Therapy Development for the Neuropsychiatric Symptoms of Dementia a. Pharmacological Researcher and Organization Principal Investigator LYKETSOS, CONSTANTINE G Principal Investigator First Name CONSTANTINE Principal Investigator Last Name LYKETSOS Awardee Organization JOHNS HOPKINS UNIVERSITY Awardee State Maryland Contact PI Country United States Project Detail Funding Opportunity Announcement PA-18-591: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp - Clinical Trial Optional) FY Overall Cost $379,256 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official RYAN, LAURIE M Related Resources Clinical Trial Escitalopram for Agitation in Alzheimer's Disease
